Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Non-Current Debt (2022 - 2026)

HeartSciences filings provide 4 years of Non-Current Debt readings, the most recent being $421564.0 for Q1 2026.

  • On a quarterly basis, Non-Current Debt changed N/A to $421564.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $421564.0, a N/A change, with the full-year FY2023 number at $500000.0, down 88.74% from a year prior.
  • Non-Current Debt hit $421564.0 in Q1 2026 for HeartSciences, up from $49470.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $4.4 million in Q2 2022 to a low of $49470.0 in Q4 2024.
  • Median Non-Current Debt over the past 4 years was $500000.0 (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 88.74% in 2023 and later changed 0.0% in 2024.
  • HeartSciences' Non-Current Debt stood at $1.0 million in 2022, then crashed by 50.0% to $500000.0 in 2023, then plummeted by 90.11% to $49470.0 in 2024, then skyrocketed by 752.16% to $421564.0 in 2026.
  • The last three reported values for Non-Current Debt were $421564.0 (Q1 2026), $49470.0 (Q4 2024), and $500000.0 (Q3 2024) per Business Quant data.